The chemical class known as NYD-SP29 Activators encompasses a diverse range of compounds that can influence the activity of the protein NYD-SP29. These activators do not interact with NYD-SP29 directly but instead, they engage with various cellular mechanisms that are crucial for the proper function and regulation of this protein. The primary mode of action for these chemicals involves targeting pathways that are essential for the assembly, maintenance, and function of cilia, where NYD-SP29 is a key component. For example, some activators in this class work by affecting the stability of microtubules, an integral part of the ciliary structure. Others modulate cellular signaling processes that govern ciliogenesis, the process by which cilia are formed, or ciliary beat frequency, which is vital for the functional motility of cilia.
Activators in this class also encompass compounds that influence gene expression related to ciliary function or affect cellular differentiation processes that, in turn, can alter ciliary assembly and maintenance. Some interact with specific enzymes or cellular pathways that regulate the dynamics of cilia, thus indirectly contributing to the regulation of NYD-SP29 activity within these organelles. By modulating these pathways, such chemicals can maintain the structural and functional integrity of cilia, ensuring that NYD-SP29 carries out its role effectively within the ciliary architecture. It is through the alteration of such broad cellular processes that these activators can impact the activity of NYD-SP29, which plays a crucial role in the structural and functional efficacy of cilia. The diversity of this chemical class reflects the complex and multi-faceted nature of ciliary function, and the role that NYD-SP29 activators play is critical to the nuanced regulation of ciliary dynamics.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, which could possibly activate NYD-SP29 by stabilizing microtubules and enhancing ciliogenesis, thereby affecting the function of NYD-SP29 in cilia. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Cholesterol is crucial for membrane composition, essential for ciliary membrane formation; it could possibly activate NYD-SP29 by influencing the proper localization and function of NYD-SP29 within cilia. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid modulates gene expression and cellular differentiation, which could possibly activate NYD-SP29 by promoting the formation of functional cilia that require NYD-SP29. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel stabilizes microtubules, which could possibly activate NYD-SP29 by supporting the structural integrity of cilia and indirectly affecting NYD-SP29's role within the dynein complex. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Olaparib, a PARP inhibitor, could possibly activate NYD-SP29 by influencing cellular repair mechanisms and may have a role in the maintenance of ciliary functions involving NYD-SP29. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Niclosamide affects calcium signaling and has been noted to affect ciliary beat frequency, which could possibly activate NYD-SP29 by affecting NYD-SP29 function. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $51.00 $101.00 $255.00 $357.00 $714.00 | 17 | |
Azithromycin has been observed to increase ciliary beat frequency, which could possibly activate NYD-SP29 by enhancing the movement of cilia involving NYD-SP29. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Roscovitine is a Cdk inhibitor that alters cell cycle progression and has been suggested to affect ciliogenesis, which could possibly activate NYD-SP29 by influencing NYD-SP29's function. | ||||||
Zileuton | 111406-87-2 | sc-204417 sc-204417A sc-204417B sc-204417C | 10 mg 50 mg 1 g 75 g | $82.00 $301.00 $362.00 $1229.00 | 8 | |
Zileuton, a 5-lipoxygenase inhibitor, could possibly activate NYD-SP29 by modulating inflammatory responses that may impact ciliary function and thus NYD-SP29 activity. |